BCL2 and diffuse large B-cell lymphoma: Moreover, high-concentration PGD2 could enhance the cytotoxicity of DNA damage drugs, adriamycin and bendamustine, and Bcl-2 inhibitor venetoclax in DLBCL cells through inducing ROS-mediated DNA damage.